Skip to Content Facebook Feature Image

ATEC Partners with FPT for First Global Collaboration, Driving Innovation in Japan’s Automotive Industry

News

ATEC Partners with FPT for First Global Collaboration, Driving Innovation in Japan’s Automotive Industry
News

News

ATEC Partners with FPT for First Global Collaboration, Driving Innovation in Japan’s Automotive Industry

2025-07-29 12:21 Last Updated At:12:41

TOKYO--(BUSINESS WIRE)--Jul 29, 2025--

Global IT services and technology company FPT and ATEC, a Japanese automotive software development firm with over 36 years of expertise, have signed a Memorandum of Understanding to establish a strategic partnership aimed at accelerating innovation in the automotive sector and advancing safer, smarter, and more connected mobility. Through this collaboration, FPT and ATEC will co-develop next-generation automotive software solutions and contribute to the sustainable growth of Japan’s automotive technology ecosystem.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250728303779/en/

The collaboration aims to address critical industry challenges, including the rising demand for software development and the shortage of senior-level talent in embedded systems and the automotive sector. By combining both sides’ technology capabilities, development frameworks, and skilled workforce, FPT and ATEC are positioned to deliver comprehensive, high-quality solutions to the market, with a particular focus on expanding AUTOSAR and Software-Defined Vehicle services for leading Japanese automotive manufacturers. As part of the partnership, FPT and ATEC will launch a new Offshore Development Center in Ho Chi Minh City, with a plan for further expansion in the future.

This marks ATEC’s first international collaboration, driven by the need to address growing resource shortages and scale its development capacity. The partnership also offers FPT valuable access to ATEC’s customer ecosystem, reinforcing its presence and competitiveness in Japan’s dynamic automotive industry.

“Automotive stands as a critical industry in Japan, with increasing AI-driven automotive systems. By combining FPT’s global expertise in automotive technology and our AI-enabled solutions with ATEC’s deep domain knowledge, we are confident that this partnership can open up exciting opportunities for both sides in Japan’s dynamic automotive sector,” said Do Van Khac, FPT Software SEVP and FPT Japan CEO, FPT Corporation.

With more than two decades of experience in the automotive industry, FPT has established itself as a trusted technology partner to global OEMs and Tier-1 suppliers. In 2023, the company launched a dedicated automotive subsidiary to address the growing global demand for software-defined vehicles. FPT’s strong presence in Japan is expected to significantly contribute to the success of this collaboration. As one of the largest foreign-invested technology enterprises in the country, FPT has over 4,500 employees across 17 offices and innovation hubs in Japan, supported by a network of 15,000 offshore professionals serving 450 clients worldwide. In 2024, FPT achieved over USD 500 million in revenue from the Japanese market. Building on this momentum, the company aims to reach USD 1 billion in revenue and rank among Japan’s Top 15 IT services providers by 2027.

About ATEC

ATEC is an engineering company established in 1988 with the vision of creating a company for engineers, boasting advanced expertise in the fields of software, electronics/electrical, and mechanical design and development. In the automotive industry, ATEC has contributed to the development of advanced technologies for numerous automakers and suppliers. In the field of in-vehicle software development, ATEC has been certified as an “Engineering Partner” by Vector Informatik (Germany), and provides high-quality services tailored to diverse customer needs, such as configuration of AUTOSAR-compliant basic software, software component design, AUTOSAR adaptation of existing code, and implementation consulting.

About FPT

FPT Corporation (FPT) is a globally leading technology and IT services provider headquartered in Vietnam and operates in three core sectors: Technology, Telecommunications, and Education. Over more than three decades, FPT has consistently delivered impactful solutions to millions of individuals and tens of thousands of organizations worldwide. Committed to elevating Vietnam’s position on the global tech map and delivering world-class AI-enabled solutions for global enterprises, the Corporation focuses on three critical transformations: Digital Transformation, Intelligence Transformation, and Green Transformation. In 2024, FPT reported a total revenue of USD 2.47 billion and a workforce of over 54,000 employees across its core businesses. For more information about FPT's global IT services, please visit https://fptsoftware.com/.

Toru Tachibana, Executive Vice President, ATEC (L) and Do Van Khac, FPT Software SEVP and FPT Japan CEO, FPT Corporation (R)

Toru Tachibana, Executive Vice President, ATEC (L) and Do Van Khac, FPT Software SEVP and FPT Japan CEO, FPT Corporation (R)

NEWARK, Del.--(BUSINESS WIRE)--Jan 15, 2026--

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier pharmacovigilance system designed to support comprehensive safety case management for clinical trials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115711485/en/

The adoption of the Oracle Argus drug safety platform underscores QPS’s commitment to advancing patient safety, regulatory compliance, and operational excellence across its clients’ clinical drug development programs. Integrating this industry-standard safety platform strengthens QPS’ ability to capture, manage, and report adverse events in accordance with global regulatory requirements.

“Ensuring patient safety and data integrity is at the heart of what we do when conducting clinical trials,” said Derek Grimes, Executive Vice President of QPS. “Oracle Argus provides us with a robust, scalable solution to support the growing needs of our customer’s clinical trial portfolios and the evolving expectations of regulatory authorities worldwide.”

“Oracle Argus provides QPS Holdings, LLC with a trusted, globally recognized drug safety platform that supports compliance with stringent pharmacovigilance standards and regulations, while streamlining end-to-end safety operations and insights at scale,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “With our industry-leading solutions, QPS Holdings, LLC can further transform and elevate its safety case management for customers worldwide.”

The deployment of Oracle Argus will enable QPS to:

As the demand for innovative therapies continues to rise, CROs play a critical role in managing both development speed and patient safety. By leveraging the Oracle Argus platform, QPS is well-positioned to deliver on its mission to accelerate pharmaceutical breakthroughs across the globe by delivering custom-built research services.

###

ABOUT QPS HOLDINGS, LLC

QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,200+ employees in the US, Europe, Asia and India. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, PBMC processing, central safety labs, clinical trials, and clinical research services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, turnkey laboratories, Phase I/II clinical units, and multi-site clinical research services. For more information, visit http://www.qps.com or email info@qps.com.

ABOUT ORACLE ARGUS

Oracle Argus is an industry-leading, trusted solution for processing, analyzing, and reporting adverse event cases originating in pre-market and post-market drugs, biologics, vaccines, devices, and combination products. Oracle has been a Leader in the IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Technology Solutions and Consulting Services 2025 Vendor Assessment (doc # US53669225, July 2025). To learn more about Oracle’s pharmacovigilance portfolio visit: https://www.oracle.com/life-sciences/safety-solutions/argus-safety-case-management/. Trademarks: Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation.

Derek Grimes, EVP, Global Head of Clinical Research at QPS Holdings, LLC.

Derek Grimes, EVP, Global Head of Clinical Research at QPS Holdings, LLC.

Recommended Articles